ArticleCancers2024

Cost-Effectiveness of PARP Inhibitors for Patients with BRCA1/2-Positive Metastatic Castration-Resistant Prostate Cancer-The Canadian Perspective.

Ivan Yanev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.